I Took Cardarine for 30 Days. Expectations Destroyed

About this video

• Video Title: I Took Cardarine for 30 Days. Expectations Destroyed
• Channel: Natty Plus Protocol
• Speakers: None explicitly named
• Duration: 00:09:30

Overview

This video details the speaker's 30-day experiment with Cardarine, focusing on its effects on biomarkers, physique, and subjective experience. The speaker shares unexpected outcomes, including impressive physique changes and concerning biomarker results, while also exploring potential properties of Cardarine that are not commonly discussed.

Key takeaways

• Cardarine's dual nature: While known as an exercise mimetic that enhances fat burning and endurance, the speaker's experience showed mixed results, with some biomarkers worsening and no noticeable subjective improvements in energy or endurance.
• Cancer concern analysis: The speaker dismisses the common cancer concern associated with Cardarine, citing a flawed rodent study with extremely high doses and suggesting that at sensible dosages, it may be anti-cancer, similar to exercise.
• Biomarker results:
  • Cholesterol: The impact on cholesterol was unclear due to concurrent dietary changes (cyclical ketogenic diet), but levels remained close to average.
  • HBA1C: An increase was observed, but attributed to "physiological insulin resistance" from the ketogenic diet rather than Cardarine.
  • Ferritin: A shocking increase in iron stores was noted, theorized to be linked to Cardarine mimicking exercise-induced erythropoiesis, which reduces hepcidin and increases iron availability.
• Physique transformation: Despite not expecting muscle gain, the speaker appeared larger, which is theorized to be due to enhanced fat metabolism and increased muscle glycogen storage, making muscles appear fuller.
• Personal conclusion: The speaker did not experience significant subjective benefits or conclusive biomarker improvements, leading to a current lack of motivation to continue using Cardarine, though acknowledging that individual experiences may vary.